Top Markets
Coin of the day
Lumosa Therapeutics Co., Ltd. Lumosa Therapeutics Co., Ltd.

Lumosa Therapeutics Co., Ltd.

6535
Kedudukan dalam Saham #14759
Lumosa Therapeutics Co., Ltd. is a clinical-stage pharmaceutical company,... Lumosa Therapeutics Co., Ltd. is a clinical-stage pharmaceutical company, headquartered in Taiwan, focused on developing innovative therapies for neurological and oncological diseases. Its most advanced product, LT-1001, an injectable analgesic, has completed Phase III clinical trials for the management of severe post-operative pain. The company's pipeline also includes LT3001, currently in Phase II for treating acute ischemic stroke; LT5001, which has finished Phase Ib trials for uremic pruritus; and LT2003, an oncology drug candidate in its preclinical development stage. Founded in 2000, Lumosa Therapeutics maintains its operational base in Taipei.
Harga Saham
$2.35
Modal Pasaran
$394.12M
Perubahan (1 hari)
-1.07%
Perubahan (1 tahun)
-64.75%
Negara
TW
Perdagangan Lumosa Therapeutics Co., Ltd. (6535)

Kategori

Sejarah harga saham bagi Lumosa Therapeutics Co., Ltd. (6535)
Harga penutupan tertinggi: $2.35 pada 2026-09-01

Harga penutupan terendah: $1.29 pada 2015-07-01
Sejarah harga saham Lumosa Therapeutics Co., Ltd. dari 2015 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) -11.24%
2025 -7.99%
2024 206.71%
2023 67.55%
2022 -8.12%
2021 11.91%
2020 4.84%
2019 18.82%
2018 1.29%
2017 -28.93%
2016 -36.03%
2015 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$544.38 39.22%
US
$1.03K 45.21%
NL
$121.37 -11.93%
AU
$138.80 476.17%
US
$750.42 5.18%
CH